{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:42:17Z","timestamp":1790221337322,"version":"4.1.0"},"reference-count":201,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS115951"],"award-info":[{"award-number":["R01NS115951"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS126866"],"award-info":[{"award-number":["R21NS126866"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.neurot.2024.e00469","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T13:51:28Z","timestamp":1730901088000},"page":"e00469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Gut microbiota immune cross-talk in amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"21","author":[{"given":"Megha","family":"Kaul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debanjan","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard L.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2024.e00469_bib1","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","article-title":"ALS genetics, mechanisms, and therapeutics: where are we now?","volume":"13","author":"Mejzini","year":"2019","journal-title":"Front Neurosci"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00469_bib2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","article-title":"Epidemiology of amyotrophic lateral sclerosis: an update of recent literature","volume":"32","author":"Longinetti","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neurot.2024.e00469_bib3","first-page":"49","article-title":"The genetics of amyotrophic lateral sclerosis: current insights","volume":"6","author":"Alsultan","year":"2016","journal-title":"Degener Neurol Neuromuscul Dis"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00469_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-022-00612-2","article-title":"Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation","volume":"22","author":"Mead","year":"2023","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00469_bib5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/jnnp.62.6.562","article-title":"British motor neuron disease twin study","volume":"62","author":"Graham","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Jan","key":"10.1016\/j.neurot.2024.e00469_bib6","article-title":"Unraveling the complex interplay between genes, environment, and climate in ALS","volume":"75","author":"Vasta","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.neurot.2024.e00469_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-072X-13-1","article-title":"Mapping amyotrophic lateral sclerosis lake risk factors across northern New England","volume":"13","author":"Torbick","year":"2014","journal-title":"Int J Health George"},{"key":"10.1016\/j.neurot.2024.e00469_bib8","article-title":"ALS risk factors: industrial airborne chemical releases","volume":"295","author":"Andrew","year":"1987","journal-title":"Environ Pollut Barking Essex"},{"issue":"10","key":"10.1016\/j.neurot.2024.e00469_bib9","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.neurol.2019.04.007","article-title":"ALS and environment: clues from spatial clustering?","volume":"175","author":"Spencer","year":"2019","journal-title":"Rev Neurol (Paris)"},{"issue":"12","key":"10.1016\/j.neurot.2024.e00469_bib10","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1136\/jnnp-2020-323611","article-title":"Untargeted metabolomics yields insight into ALS disease mechanisms","volume":"91","author":"Goutman","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00469_bib11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.21147","article-title":"Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations","volume":"61","author":"Mackenzie","year":"2007","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00469_bib12","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","article-title":"TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"351","author":"Arai","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neurot.2024.e00469_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2019.00262","article-title":"Prion-Like propagation of protein misfolding and aggregation in amyotrophic lateral sclerosis","author":"McAlary","year":"2019","journal-title":"Front Mol Neurosci [Internet]"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1474-4422(17)30401-5","article-title":"Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications","volume":"17","author":"Chia","year":"2018","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00469_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00401-012-1022-4","article-title":"The genetics and neuropathology of amyotrophic lateral sclerosis","volume":"124","author":"Al-Chalabi","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurot.2024.e00469_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ddmod.2018.10.001","article-title":"Modelling amyotrophic lateral sclerosis in mice","volume":"25\u201326","author":"Stephenson","year":"2017","journal-title":"Drug Discov Today Dis Model"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00469_bib17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/jnen\/nlaa003","article-title":"Characteristic features of FUS inclusions in spinal motor neurons of sporadic amyotrophic lateral sclerosis","volume":"79","author":"Ikenaka","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"issue":"8","key":"10.1016\/j.neurot.2024.e00469_bib18","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/jnnp-2018-319386","article-title":"Misfolded SOD1 inclusions in patients with mutations in C9orf72 and other ALS\/FTD-associated genes","volume":"90","author":"Forsberg","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00469_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00438-013-0741-0","article-title":"The wobbler mouse, an ALS animal model","volume":"288","author":"Moser","year":"2013","journal-title":"Mol Genet Genom"},{"issue":"7\u20138","key":"10.1016\/j.neurot.2024.e00469_bib20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/21678421.2020.1779298","article-title":"Focus on the heterogeneity of amyotrophic lateral sclerosis","volume":"21","author":"Bendotti","year":"2020","journal-title":"Amyotroph Lateral Scler Front Degener"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00469_bib21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1474-4422(13)70036-X","article-title":"Controversies and priorities in amyotrophic lateral sclerosis","volume":"12","author":"Turner","year":"2013","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00469_bib22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/jnnp-2016-315018","article-title":"Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"88","author":"Zou","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurot.2024.e00469_bib23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3389\/fneur.2019.00527","article-title":"Structural properties and interaction partners of familial ALS-associated SOD1 mutants","volume":"10","author":"Huai","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurot.2024.e00469_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40035-015-0036-y","article-title":"Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis","volume":"4","author":"Yamashita","year":"2015","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.neurot.2024.e00469_bib25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1750-1326-8-28","article-title":"Genetics of amyotrophic lateral sclerosis: an update","volume":"8","author":"Chen","year":"2013","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.neurot.2024.e00469_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31773-z","article-title":"Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis","volume":"8","author":"Par\u00e9","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00469_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gene.2015.11.049","article-title":"Mutant SOD1 mediated pathogenesis of amyotrophic lateral sclerosis","volume":"577","author":"Kaur","year":"2016","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00469_bib28","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1073\/pnas.92.4.954","article-title":"Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons","volume":"92","author":"Pardo","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurot.2024.e00469_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1208673","article-title":"Another de novo mutation in the SOD1 gene: the first Turkish patient with SOD1-His47Arg, a case report","volume":"14","author":"Bayraktar","year":"2023","journal-title":"Front Genet"},{"key":"10.1016\/j.neurot.2024.e00469_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jbior.2015.10.006","article-title":"SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS","volume":"60","author":"Hayashi","year":"2016","journal-title":"Adv Biol Regul"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00469_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.410390203","article-title":"Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis","volume":"39","author":"Gurney","year":"1996","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00469_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-2001-15268","article-title":"Clinical characteristics and management of ALS","volume":"21","author":"Borasio","year":"2001","journal-title":"Semin Neurol"},{"issue":"7770","key":"10.1016\/j.neurot.2024.e00469_bib33","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-019-1443-5","article-title":"Potential roles of gut microbiome and metabolites in modulating ALS in mice","volume":"572","author":"Blacher","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib34","first-page":"135","article-title":"Microbiota signaling pathways that influence neurologic disease","volume":"15","author":"Cox","year":"2018","journal-title":"Neurother J Am Soc Exp Neurother"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00469_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126942","article-title":"Emerging small-molecule therapeutic approaches for amyotrophic lateral sclerosis and frontotemporal dementia","volume":"30","author":"Brown","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"issue":"Pt 2","key":"10.1016\/j.neurot.2024.e00469_bib36","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/brain\/114.2.775","article-title":"Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity","volume":"114","author":"Leigh","year":"1991","journal-title":"Brain J Neurol"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00469_bib37","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4161\/rna.7.4.12205","article-title":"The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation","volume":"7","author":"Buratti","year":"2010","journal-title":"RNA Biol"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00469_bib38","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nn.2778","article-title":"Characterising the RNA targets and position-dependent splicing regulation by TDP-43; implications for neurodegenerative diseases","volume":"14","author":"Tollervey","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurot.2024.e00469_bib39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","article-title":"Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis","volume":"12","author":"Prasad","year":"2019","journal-title":"Front Mol Neurosci"},{"issue":"5918","key":"10.1016\/j.neurot.2024.e00469_bib40","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1166066","article-title":"Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis","volume":"323","author":"Kwiatkowski","year":"2009","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13024-024-00718-8","article-title":"HDGFL2 cryptic proteins report presence of TDP-43 pathology in neurodegenerative diseases","volume":"19","author":"Calliari","year":"2024","journal-title":"Mol Neurodegener"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00469_bib42","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41591-023-02788-5","article-title":"A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD","volume":"30","author":"Irwin","year":"2024","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00469_bib43","article-title":"ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair","volume":"22","author":"Klim","year":"2019","journal-title":"Nat Neurosci [Internet]"},{"issue":"7899","key":"10.1016\/j.neurot.2024.e00469_bib44","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41586-022-04424-7","article-title":"TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"},{"issue":"5918","key":"10.1016\/j.neurot.2024.e00469_bib45","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1165942","article-title":"Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6","volume":"323","author":"Vance","year":"2009","journal-title":"Science"},{"issue":"Pt 15","key":"10.1016\/j.neurot.2024.e00469_bib46","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1242\/jcs.110.15.1741","article-title":"TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling","volume":"110","author":"Zinszner","year":"1997","journal-title":"J Cell Sci"},{"issue":"Suppl 1","key":"10.1016\/j.neurot.2024.e00469_bib47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/jnc.13625","article-title":"Physiological functions and pathobiology of TDP-43 and FUS\/TLS proteins","volume":"138","author":"Ratti","year":"2016","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib48","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40478-015-0202-6","article-title":"FUS\/TLS deficiency causes behavioral and pathological abnormalities distinct from amyotrophic lateral sclerosis","volume":"3","author":"Kino","year":"2015","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5607\/en.2015.24.1.1","article-title":"Prion-like mechanism in amyotrophic lateral sclerosis: are protein aggregates the key?","volume":"24","author":"Lee","year":"2015","journal-title":"Exp Neurobiol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib50","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41591-021-01615-z","article-title":"Antisense oloigonucleotide silencing of FUS expression as a therapeutic approach in Amyotrophic lateral sclerosis","volume":"28","author":"A Korobeynikov","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.neurot.2024.e00469_bib51","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fncel.2017.00196","article-title":"Mouse models of C9orf72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis\/frontotemporal dementia","volume":"11","author":"Batra","year":"2017","journal-title":"Front Cell Neurosci"},{"issue":"51","key":"10.1016\/j.neurot.2024.e00469_bib52","doi-asserted-by":"crossref","first-page":"E4968","DOI":"10.1073\/pnas.1315438110","article-title":"RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia","volume":"110","author":"Zu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurot.2024.e00469_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.661447","article-title":"C9ORF72: what it is, what it does, and why it matters","volume":"15","author":"Smeyers","year":"2021","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00469_bib54","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"issue":"Suppl 1","key":"10.1016\/j.neurot.2024.e00469_bib55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/jnc.13623","article-title":"Insights into the pathogenic mechanisms of Chromosome 9 open reading frame 72 (C9orf72) repeat expansions","volume":"138","author":"Todd","year":"2016","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00469_bib56","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/ana.24453","article-title":"C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits","volume":"78","author":"Koppers","year":"2015","journal-title":"Ann Neurol"},{"issue":"6279","key":"10.1016\/j.neurot.2024.e00469_bib57","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1126\/science.aaf1064","article-title":"C9orf72 is required for proper macrophage and microglial function in mice","volume":"351","author":"O'Rourke","year":"2016","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00469_bib58","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.neuron.2015.11.018","article-title":"Human C9ORF72 hexanucleotide expansion reproduces RNA foci and dipeptide repeat proteins but not neurodegeneration in BAC transgenic mice","volume":"88","author":"Peters","year":"2015","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00469_bib59","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.neuron.2016.04.005","article-title":"C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS\/FTD","volume":"90","author":"Liu","year":"2016","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00469_bib60","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.neuron.2020.08.009","article-title":"Absence of survival and motor deficits in 500 repeat C9ORF72 BAC mice","volume":"108","author":"Mordes","year":"2020","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00469_bib61","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of intestinal Th17 cells by segmented filamentous bacteria","volume":"139","author":"Ivanov","year":"2009","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00469_bib62","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nn2047","article-title":"Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis","volume":"11","author":"Yamanaka","year":"2008","journal-title":"Nat Neurosci"},{"issue":"5642","key":"10.1016\/j.neurot.2024.e00469_bib63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1126\/science.1086071","article-title":"Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice","volume":"302","author":"Clement","year":"2003","journal-title":"Science"},{"issue":"5778","key":"10.1016\/j.neurot.2024.e00469_bib64","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.1123511","article-title":"Onset and progression in inherited ALS determined by motor neurons and microglia","volume":"312","author":"Boill\u00e9e","year":"2006","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00469_bib65","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/mus.10191","article-title":"Inflammatory processes in amyotrophic lateral sclerosis","volume":"26","author":"McGeer","year":"2002","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00469_bib66","first-page":"364","article-title":"Protective and toxic neuroinflammation in amyotrophic lateral sclerosis","volume":"12","author":"Hooten","year":"2015","journal-title":"Neurother J Am Soc Exp Neurother"},{"key":"10.1016\/j.neurot.2024.e00469_bib67","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mcn.2012.10.008","article-title":"Inflammation and neurovascular changes in amyotrophic lateral sclerosis","volume":"53","author":"Evans","year":"2013","journal-title":"Mol Cell Neurosci"},{"issue":"46","key":"10.1016\/j.neurot.2024.e00469_bib68","doi-asserted-by":"crossref","first-page":"17913","DOI":"10.1073\/pnas.0804610105","article-title":"T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS","volume":"105","author":"Chiu","year":"2008","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3","key":"10.1016\/j.neurot.2024.e00469_bib69","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00401-016-1548-y","article-title":"Peripheral monocytes are functionally altered and invade the CNS in ALS patients","volume":"132","author":"Zondler","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurot.2024.e00469_bib70","first-page":"61","article-title":"Pathology of amyotrophic lateral sclerosis","volume":"36","author":"Hughes","year":"1982","journal-title":"Adv Neurol"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00469_bib71","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00005072-198607000-00001","article-title":"Anterior horn changes of motor neuron disease associated with demyelinating radiculopathy","volume":"45","author":"Ghatak","year":"1986","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00469_bib72","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1440-1789.2007.00873.x","article-title":"Bunina bodies in amyotrophic lateral sclerosis","volume":"28","author":"Okamoto","year":"2008","journal-title":"Neuropathol Off J Jpn Soc Neuropathol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib73","article-title":"Immune-related genetic enrichment in frontotemporal dementia: an analysis of genome-wide association studies","volume":"15","author":"Broce","year":"2018","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00469_bib74","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa124","article-title":"Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses","volume":"2","author":"B\u00e9land","year":"2020","journal-title":"Brain Commun"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib75","first-page":"4","article-title":"The microglial-motoneuron dialogue in ALS","volume":"30","author":"Appel","year":"2011","journal-title":"Acta Myol Myopathies Cardiomyopathies Off J Mediterr Soc Myol"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00469_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039216","article-title":"Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis","volume":"7","author":"Brettschneider","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib77","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ana.24304","article-title":"Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice","volume":"77","author":"Butovsky","year":"2015","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00469_bib78","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1468-1331.2009.02560.x","article-title":"Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis","volume":"16","author":"Kuhle","year":"2009","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib79","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/mus.21683","article-title":"Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics","volume":"42","author":"Ryberg","year":"2010","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib80","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12974-015-0439-9","article-title":"PET imaging studies show enhanced expression of mGluR5 and inflammatory response during progressive degeneration in ALS mouse model expressing SOD1-G93A gene","volume":"12","author":"Brownell","year":"2015","journal-title":"J Neuroinflammation"},{"issue":"6005","key":"10.1016\/j.neurot.2024.e00469_bib81","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1194637","article-title":"Fate mapping analysis reveals that adult microglia derive from primitive macrophages","volume":"330","author":"Ginhoux","year":"2010","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00469_bib82","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.nbd.2003.12.012","article-title":"Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study","volume":"15","author":"Turner","year":"2004","journal-title":"Neurobiol Dis"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00469_bib83","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nn1472","article-title":"ATP mediates rapid microglial response to local brain injury in vivo","volume":"8","author":"Davalos","year":"2005","journal-title":"Nat Neurosci"},{"issue":"5726","key":"10.1016\/j.neurot.2024.e00469_bib84","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib85","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/glia.22389","article-title":"The \u2018quad-partite\u2019 synapse: microglia-synapse interactions in the developing and mature CNS","volume":"61","author":"Schafer","year":"2013","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00469_bib86","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/glia.22444","article-title":"Extracellular aggregated Cu\/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype","volume":"61","author":"Roberts","year":"2013","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00469_bib87","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/glia.20919","article-title":"Extracellular mutant SOD1 induces microglial-mediated motoneuron injury","volume":"58","author":"Zhao","year":"2010","journal-title":"Glia"},{"issue":"10","key":"10.1016\/j.neurot.2024.e00469_bib88","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41583-018-0057-5","article-title":"Microglial signatures and their role in health and disease","volume":"19","author":"Butovsky","year":"2018","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00469_bib89","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1084\/jem.20180729","article-title":"Heterozygous Tbk1 loss has opposing effects in early and late stages of ALS in mice","volume":"216","author":"Brenner","year":"2019","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00469_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036000","article-title":"Early functional deficit and microglial disturbances in a mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Gerber","year":"2012","journal-title":"PLoS One"},{"issue":"6435","key":"10.1016\/j.neurot.2024.e00469_bib91","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.aav9776","article-title":"Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis","volume":"364","author":"Maniatis","year":"2019","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.neurot.2024.e00469_bib92","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1073\/pnas.0802556105","article-title":"Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice","volume":"105","author":"Yamanaka","year":"2008","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib93","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40478-016-0306-7","article-title":"C9orf72 is differentially expressed in the central nervous system and myeloid cells and consistently reduced in C9orf72, MAPT and GRN mutation carriers","volume":"4","author":"Rizzu","year":"2016","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00469_bib94","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41593-018-0083-7","article-title":"Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy","volume":"21","author":"Spiller","year":"2018","journal-title":"Nat Neurosci"},{"issue":"8","key":"10.1016\/j.neurot.2024.e00469_bib95","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.cell.2024.02.031","article-title":"Single-cell dissection of the human motor and prefrontal cortices in ALS and FTLD","volume":"187","author":"Pineda","year":"2024","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00469_bib96","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/s43587-024-00640-0","article-title":"Single-nucleus sequencing reveals enriched expression of genetic risk factors in extratelencephalic neurons sensitive to degeneration in ALS","volume":"4","author":"Limone","year":"2024","journal-title":"Nat Aging"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00469_bib97","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nn1876","article-title":"Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons","volume":"10","author":"Nagai","year":"2007","journal-title":"Nat Neurosci"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00469_bib98","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nn1885","article-title":"Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model","volume":"10","author":"Di Giorgio","year":"2007","journal-title":"Nat Neurosci"},{"issue":"43","key":"10.1016\/j.neurot.2024.e00469_bib99","doi-asserted-by":"crossref","first-page":"17803","DOI":"10.1073\/pnas.1103141108","article-title":"Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo","volume":"108","author":"Papadeas","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00469_bib100","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.stemcr.2017.03.003","article-title":"Sporadic ALS astrocytes induce neuronal degeneration in vivo","volume":"8","author":"Qian","year":"2017","journal-title":"Stem Cell Rep"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00469_bib101","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1073\/pnas.1314085111","article-title":"Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS","volume":"111","author":"Meyer","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00469_bib102","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.neuron.2014.01.011","article-title":"Necroptosis drives motor neuron death in models of both sporadic and familial ALS","volume":"81","author":"Re","year":"2014","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00469_bib103","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nm.4106","article-title":"Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor","volume":"22","author":"Rothhammer","year":"2016","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib104","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/archneur.1993.00540010026013","article-title":"Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis","volume":"50","author":"Engelhardt","year":"1993","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00469_bib105","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2174\/156652411795243450","article-title":"The Role of immune and inflammatory mechanisms in ALS","volume":"11","author":"McCombe","year":"2011","journal-title":"Curr Mol Med"},{"issue":"11","key":"10.1016\/j.neurot.2024.e00469_bib106","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001205","article-title":"Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS","volume":"2","author":"Garbuzova-Davis","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2024.e00469_bib107","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fncel.2013.00214","article-title":"Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis","volume":"7","author":"Bowerman","year":"2013","journal-title":"Front Cell Neurosci"},{"issue":"40","key":"10.1016\/j.neurot.2024.e00469_bib108","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0807419105","article-title":"CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS","volume":"105","author":"Beers","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 5","key":"10.1016\/j.neurot.2024.e00469_bib109","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/brain\/awr074","article-title":"Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis","volume":"134","author":"Beers","year":"2011","journal-title":"Brain J Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib110","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/emmm.201201544","article-title":"Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival","volume":"5","author":"Henkel","year":"2013","journal-title":"EMBO Mol Med"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00469_bib111","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89530","article-title":"ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity","volume":"2","author":"Beers","year":"2017","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib112","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.clim.2013.04.010","article-title":"T helper-17 activation dominates the immunologic milieu of both amyotrophic lateral sclerosis and progressive multiple sclerosis","volume":"148","author":"Saresella","year":"2013","journal-title":"Clin Immunol Orlando Fla"},{"key":"10.1016\/j.neurot.2024.e00469_bib113","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1742-2094-7-76","article-title":"IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients","volume":"7","author":"Fiala","year":"2010","journal-title":"J Neuroinflammation"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00469_bib114","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200019","article-title":"Combined regulatory T-lymphocyte and IL-2 treatment is safe, tolerable, and biologically active for 1 Year in persons with amyotrophic lateral sclerosis","volume":"9","author":"Thonhoff","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib115","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1038\/s41467-022-34526-9","article-title":"T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression","volume":"13","author":"Yazdani","year":"2022","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00469_bib116","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jamaneurol.2017.0357","article-title":"Characterization of gene expression phenotype in amyotrophic lateral sclerosis monocytes","volume":"74","author":"Zhao","year":"2017","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00469_bib117","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000242","article-title":"Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis","volume":"3","author":"Murdock","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00469_bib118","article-title":"Peripheral immune profiles predict ALS progression in an age- and sex-dependent manner","volume":"11","author":"Bj","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflammation [Internet]"},{"issue":"1\u20132","key":"10.1016\/j.neurot.2024.e00469_bib119","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jneuroim.2014.09.005","article-title":"Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood","volume":"276","author":"Mantovani","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurot.2024.e00469_bib120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13395-017-0128-8","article-title":"Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Wang","year":"2017","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.neurot.2024.e00469_bib121","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nbd.2019.03.003","article-title":"Revisiting the role of the innate immune complement system in ALS","volume":"127","author":"Parker","year":"2019","journal-title":"Neurobiol Dis"},{"issue":"12","key":"10.1016\/j.neurot.2024.e00469_bib122","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1001\/jamaneurol.2017.2255","article-title":"Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression","volume":"74","author":"Murdock","year":"2017","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib123","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s41467-020-15644-8","article-title":"Natural killer cells modulate motor neuron-immune cell cross talk in models of Amyotrophic Lateral Sclerosis","volume":"11","author":"Garofalo","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib124","doi-asserted-by":"crossref","first-page":"7853","DOI":"10.1038\/s41598-017-08233-1","article-title":"Inflammatory role of dendritic cells in Amyotrophic Lateral Sclerosis revealed by an analysis of patients' peripheral blood","volume":"7","author":"Rusconi","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00469_bib125","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ana.10805","article-title":"Presence of dendritic cells, MCP-1, and activated microglia\/macrophages in amyotrophic lateral sclerosis spinal cord tissue","volume":"55","author":"Henkel","year":"2004","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00469_bib126","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.nbd.2011.01.002","article-title":"Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation","volume":"42","author":"Sta","year":"2011","journal-title":"Neurobiol Dis"},{"issue":"19","key":"10.1016\/j.neurot.2024.e00469_bib127","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123249","article-title":"Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS","volume":"3","author":"Trias","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.neurot.2024.e00469_bib128","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211030365","article-title":"Long-term survival analysis of masitinib in amyotrophic lateral sclerosis","volume":"14","author":"Mora","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"issue":"11","key":"10.1016\/j.neurot.2024.e00469_bib129","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1042\/BCJ20160510","article-title":"Introduction to the human gut microbiota","volume":"474","author":"Thursby","year":"2017","journal-title":"Biochem J"},{"issue":"8","key":"10.1016\/j.neurot.2024.e00469_bib130","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/brainsci13081226","article-title":"Emerging Paradigms in inflammatory disease management: exploring bioactive compounds and the gut microbiota","volume":"13","author":"Benameur","year":"2023","journal-title":"Brain Sci"},{"issue":"29","key":"10.1016\/j.neurot.2024.e00469_bib131","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","article-title":"Role of the normal gut microbiota","volume":"21","author":"Jandhyala","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib132","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/imr.12567","article-title":"Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease","volume":"279","author":"Pickard","year":"2017","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00469_bib133","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/mp.2016.50","article-title":"From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways","volume":"21","author":"Rogers","year":"2016","journal-title":"Mol Psychiatr"},{"issue":"8","key":"10.1016\/j.neurot.2024.e00469_bib134","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrn3071","article-title":"Gut feelings: the emerging biology of gut-brain communication","volume":"12","author":"Mayer","year":"2011","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00469_bib135","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41564-018-0307-3","article-title":"GABA-modulating bacteria of the human gut microbiota","volume":"4","author":"Strandwitz","year":"2019","journal-title":"Nat Microbiol"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00469_bib136","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.celrep.2016.04.074","article-title":"Ly6Chi monocytes provide a link between antibiotic-induced changes in gut microbiota and adult hippocampal neurogenesis","volume":"15","author":"M\u00f6hle","year":"2016","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00469_bib137","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00401-018-1856-5","article-title":"Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases?","volume":"136","author":"Pellegrini","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurot.2024.e00469_bib138","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12974-022-02510-1","article-title":"The function of gut microbiota in immune-related neurological disorders: a review","volume":"19","author":"Sittipo","year":"2022","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurot.2024.e00469_bib139","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.810483","article-title":"Enteric nervous system: the bridge between the gut microbiota and neurological disorders","volume":"14","author":"Geng","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00469_bib140","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12684","article-title":"The role of the gut microbiota in development, function and disorders of the central nervous system and the enteric nervous system","volume":"31","author":"Heiss","year":"2019","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib141","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11047-w","article-title":"Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE\/PS1\u0394E9 murine model of Alzheimer's disease","volume":"7","author":"Minter","year":"2017","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"10.1016\/j.neurot.2024.e00469_bib142","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1073\/pnas.1000082107","article-title":"Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis","volume":"108","author":"Lee","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00469_bib143","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"issue":"7810","key":"10.1016\/j.neurot.2024.e00469_bib144","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41586-020-2288-7","article-title":"C9orf72 suppresses systemic and neural inflammation induced by gut bacteria","volume":"582","author":"Burberry","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40168-022-01232-z","article-title":"The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis","volume":"10","author":"Cox","year":"2022","journal-title":"Microbiome"},{"issue":"7374","key":"10.1016\/j.neurot.2024.e00469_bib146","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature10554","article-title":"Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination","volume":"479","author":"Berer","year":"2011","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00469_bib147","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.cell.2019.05.004","article-title":"Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice","volume":"177","author":"Sharon","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.neurot.2024.e00469_bib148","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.890958","article-title":"Neuroimmune crosstalk between the peripheral and the central immune system in amyotrophic lateral sclerosis","volume":"14","author":"Yu","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"Pt 3","key":"10.1016\/j.neurot.2024.e00469_bib149","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/brain\/awr365","article-title":"Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72","volume":"135","author":"Cooper-Knock","year":"2012","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.neurot.2024.e00469_bib150","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3389\/fmicb.2016.01479","article-title":"Evaluation of the microbial diversity in amyotrophic lateral sclerosis using high-throughput sequencing","volume":"7","author":"Fang","year":"2016","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib151","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12916-020-01607-9","article-title":"A prospective longitudinal study on themicrobiota composition in amyotrophic lateral sclerosis","volume":"18","author":"Di Gioia","year":"2020","journal-title":"BMC Med"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00469_bib152","article-title":"Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model","volume":"3","author":"Wu","year":"2015","journal-title":"Phys Rep"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00469_bib153","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clinthera.2016.12.014","article-title":"Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis","volume":"39","author":"Zhang","year":"2017","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00469_bib154","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3390\/ijms20040974","article-title":"Niacin in the central nervous system: an update of biological aspects and clinical applications","volume":"20","author":"Gasperi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2024.e00469_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2017.06.052","article-title":"The role of mitochondria in amyotrophic lateral sclerosis","volume":"710","author":"Smith","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurot.2024.e00469_bib156","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-024-03988-x","article-title":"Neuroprotective effect of a multistrain probiotic mixture in SOD1G93A mice by reducing SOD1 aggregation and targeting the microbiota-gut-brain Axis","author":"Xin","year":"2024","journal-title":"Mol Neurobiol"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00469_bib157","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nn.4030","article-title":"Host microbiota constantly control maturation and function of microglia in the CNS","volume":"18","author":"Erny","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurot.2024.e00469_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2021.111376","article-title":"Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson's disease","volume":"150","author":"Hou","year":"2021","journal-title":"Exp Gerontol"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00469_bib159","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4161\/auto.27710","article-title":"MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis","volume":"10","author":"Zhang","year":"2014","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00469_bib160","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.neurot.2024.e00469_bib161","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s41590-023-01627-6","article-title":"APOE4 impairs the microglial response in Alzheimer's disease by inducing TGF\u03b2-mediated checkpoints","volume":"24","author":"Yin","year":"2023","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib162","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12974-019-1564-7","article-title":"The endotoxin hypothesis of neurodegeneration","volume":"16","author":"Brown","year":"2019","journal-title":"J Neuroinflammation"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00469_bib163","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/gutjnl-2020-322670","article-title":"Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome","volume":"70","author":"Bolte","year":"2021","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00469_bib164","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172914","article-title":"Altered gut microbiome in a mouse model of Gulf War Illness causes neuroinflammation and intestinal injury via leaky gut and TLR4 activation","volume":"12","author":"Alhasson","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00469_bib165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/vaccines5040034","article-title":"TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis","volume":"5","author":"Kuzmich","year":"2017","journal-title":"Vaccines"},{"issue":"1\u20132","key":"10.1016\/j.neurot.2024.e00469_bib166","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jneuroim.2008.09.017","article-title":"Circulating endotoxin and systemic immune activation in sporadic Amyotrophic Lateral Sclerosis (sALS)","volume":"206","author":"Zhang","year":"2009","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib167","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/cjp2.297","article-title":"pTDP-43 aggregates accumulate in non-central nervous system tissues prior to symptom onset in amyotrophic lateral sclerosis: a case series linking archival surgical biopsies with clinical phenotypic data","volume":"9","author":"Pattle","year":"2023","journal-title":"J Pathol Clin Res"},{"issue":"10","key":"10.1016\/j.neurot.2024.e00469_bib168","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140248","article-title":"Inflammation induces TDP-43 mislocalization and aggregation","volume":"10","author":"Correia","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib169","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2363880","article-title":"Probiotics and microbial metabolites maintain barrier and neuromuscular functions and clean protein aggregation to delay disease progression in TDP43 mutation mice","volume":"16","author":"Zhang","year":"2024","journal-title":"Gut Microb"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00469_bib170","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/ana.25244","article-title":"A probiotic modulates the microbiome and immunity in multiple sclerosis","volume":"83","author":"Tankou","year":"2018","journal-title":"Ann Neurol"},{"issue":"18","key":"10.1016\/j.neurot.2024.e00469_bib171","article-title":"Gut inflammation and dysbiosis in human motor neuron disease","volume":"5","author":"Rowin","year":"2017","journal-title":"Phys Rep"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib172","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69845-8","article-title":"The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients","volume":"10","author":"Zeng","year":"2020","journal-title":"Sci Rep"},{"issue":"15","key":"10.1016\/j.neurot.2024.e00469_bib173","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1097\/CM9.0000000000000351","article-title":"Intestinal microbiota composition in patients with amyotrophic lateral sclerosis: establishment of bacterial and archaeal communities analyses","volume":"132","author":"Zhai","year":"2019","journal-title":"Chin Med J"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib174","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12883-022-02586-5","article-title":"Gut- and oral-dysbiosis differentially impact spinal- and bulbar-onset ALS, predicting ALS severity and potentially determining the location of disease onset","volume":"22","author":"Kim","year":"2022","journal-title":"BMC Neurol"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00469_bib175","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7555\/JBR.36.20220198","article-title":"Gut microbiota links with cognitive impairment in amyotrophic lateral sclerosis: a multi-omics study","volume":"37","author":"Gong","year":"2023","journal-title":"J Biomed Res"},{"issue":"3\u20134","key":"10.1016\/j.neurot.2024.e00469_bib176","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/21678421.2020.1828475","article-title":"The human gut microbiota in people with amyotrophic lateral sclerosis","volume":"22","author":"Nicholson","year":"2021","journal-title":"Amyotroph Lateral Scler Front Degener"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib177","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12883-021-02522-z","article-title":"Assessment of bidirectional relationships between 98 genera of the human gut microbiota and amyotrophic lateral sclerosis: a 2-sample Mendelian randomization study","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Neurol"},{"issue":"1\u20132","key":"10.1016\/j.neurot.2024.e00469_bib178","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/21678421.2021.1904994","article-title":"Gut microbiome differences between amyotrophic lateral sclerosis patients and spouse controls","volume":"23","author":"Hertzberg","year":"2022","journal-title":"Amyotroph Lateral Scler Front Degener"},{"key":"10.1016\/j.neurot.2024.e00469_bib179","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neurobiolaging.2017.09.023","article-title":"The fecal microbiome of ALS patients","volume":"61","author":"Brenner","year":"2018","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00469_bib180","doi-asserted-by":"crossref","first-page":"579","DOI":"10.55730\/1300-0144.5825","article-title":"Is gut\u00a0microbiota of patients with ALS different from that of healthy individuals?","volume":"54","author":"\u00d6zaydin Aksun","year":"2024","journal-title":"Turk J Med Sci"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib181","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12916-020-01885-3","article-title":"The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS)","volume":"19","author":"Boddy","year":"2021","journal-title":"BMC Med"},{"issue":"7\u20138","key":"10.1016\/j.neurot.2024.e00469_bib182","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/21678421.2020.1772825","article-title":"Progression and survival of patients with motor neuron disease relative to their fecal microbiota","volume":"21","author":"Ngo","year":"2020","journal-title":"Amyotroph Lateral Scler Front Degener"},{"issue":"18","key":"10.1016\/j.neurot.2024.e00469_bib183","first-page":"e2089","article-title":"Prediagnostic plasma metabolomics and the risk of amyotrophic lateral sclerosis","volume":"92","author":"Bjornevik","year":"2019","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00469_bib184","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/awad306","article-title":"Gut microbiome correlates with plasma lipids in amyotrophic lateral sclerosis","volume":"147","author":"Guo","year":"2024","journal-title":"Brain J Neurol"},{"issue":"11","key":"10.1016\/j.neurot.2024.e00469_bib185","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/ene.13986","article-title":"Antibiotics use and risk of amyotrophic lateral sclerosis in Sweden","volume":"26","author":"Sun","year":"2019","journal-title":"Eur J Neurol"},{"issue":"12","key":"10.1016\/j.neurot.2024.e00469_bib186","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(07)70270-3","article-title":"Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial","volume":"6","author":"Gordon","year":"2007","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.neurot.2024.e00469_bib187","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1474-4422(14)70222-4","article-title":"Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial","volume":"13","author":"Cudkowicz","year":"2014","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00469_bib188","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3390\/nu11040923","article-title":"Precision nutrition and the microbiome, Part I: current state of the science","volume":"11","author":"Mills","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib189","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/WNL.50.1.66","article-title":"Prognostic indicators of survival in ALS. ALS CNTF treatment study group","volume":"50","author":"Stambler","year":"1998","journal-title":"Neurology"},{"issue":"6150","key":"10.1016\/j.neurot.2024.e00469_bib190","doi-asserted-by":"crossref","DOI":"10.1126\/science.1241214","article-title":"Gut microbiota from twins discordant for obesity modulate metabolism in mice","volume":"341","author":"Ridaura","year":"2013","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00469_bib191","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.cell.2018.04.027","article-title":"The gut microbiota mediates the anti-seizure effects of the ketogenic diet","volume":"173","author":"Olson","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.neurot.2024.e00469_bib192","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1232184","article-title":"Effect of the Mediterranean diet supplemented with nicotinamide riboside and pterostilbene and\/or coconut oil on anthropometric variables in amyotrophic lateral sclerosis. A pilot study","volume":"10","author":"Carrera-Juli\u00e1","year":"2023","journal-title":"Front Nutr"},{"key":"10.1016\/j.neurot.2024.e00469_bib193","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3389\/fnagi.2017.00398","article-title":"Exploring the association between alzheimer's disease, oral health, microbial endocrinology and nutrition","volume":"9","author":"Harding","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.neurot.2024.e00469_bib194","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fnagi.2016.00256","article-title":"Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer's disease: a randomized, double-blind and controlled trial","volume":"8","author":"Akbari","year":"2016","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-022-04295-8","article-title":"Fatty acids derived from the probiotic Lacticaseibacillus rhamnosus HA-114 suppress age-dependent neurodegeneration","volume":"5","author":"Labarre","year":"2022","journal-title":"Commun Biol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib196","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13578-020-00511-2","article-title":"CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?","volume":"11","author":"Tefera","year":"2021","journal-title":"Cell Biosci"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00469_bib197","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1021\/acsmedchemlett.3c00168","article-title":"Microbiome-Gut-Brain Axis modulation: new approaches in treatment of neuropsychological and gastrointestinal functional disorders","volume":"14","author":"Kargbo","year":"2023","journal-title":"ACS Med Chem Lett"},{"issue":"10","key":"10.1016\/j.neurot.2024.e00469_bib198","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMoa1916945","article-title":"Trial of sodium phenylbutyrate-taurursodiol for amyotrophic lateral sclerosis","volume":"383","author":"Paganoni","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00469_bib199","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nrgastro.2016.98","article-title":"Understanding the mechanisms of faecal microbiota transplantation","volume":"13","author":"Khoruts","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00469_bib200","doi-asserted-by":"crossref","first-page":"69","DOI":"10.7555\/JBR.36.20220088","article-title":"Washed microbiota transplantation stopped the deterioration of amyotrophic lateral sclerosis: the first case report and narrative review","volume":"37","author":"Lu","year":"2022","journal-title":"J Biomed Res"},{"key":"10.1016\/j.neurot.2024.e00469_bib201","article-title":"FETR-ALS study protocol: a randomized clinical trial of fecal microbiota transplantation in amyotrophic lateral sclerosis","volume":"10","author":"Mandrioli","year":"2019","journal-title":"Front Neurol [Internet]"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924001569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924001569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T13:24:22Z","timestamp":1731417862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747924001569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":201,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1878747924001569"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00469","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiota immune cross-talk in amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00469","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00469"}}